Sirolimus eluting coronary stent system, with CoCr Stent and permanent polymer. - India CDSCO Medical Device Registration

Sirolimus eluting coronary stent system, with CoCr Stent and permanent polymer. is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000218_e045c4a4e62fda8d6f58b178c98afb3c_3619a002691c57cd541e568b59fd7cf7. This device is marketed under the brand name CoCr Stent and permanent polymer. The license holder is Raymed Trading Group Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

Sirolimus eluting coronary stent system, with CoCr Stent and permanent polymer.

UID: IMP/MD/2020/000218_e045c4a4e62fda8d6f58b178c98afb3c_3619a002691c57cd541e568b59fd7cf7

Brand Name

CoCr Stent and permanent polymer

License Holder

Raymed Trading Group Private Limited

Device Class

Class D

Approving Authority

CDSCO

Product Information

The device is indicated for increasing the internal diameter of an artery with the aim of improving blood flow in the following cases: • Patients with symptomatic ischemic heart disease due to “de novo” stenotic and re-stenotic lesions located in arteries with diameters from 2mm to 4.5mm. • Patients with occlusive disease due to acute myocardial infarction located in arteries with diameters from 2mm to 4.5mm.